Geneva Advisors, LLC - ARATANA THERAPEUTICS INC ownership

ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 95 filers reported holding ARATANA THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.16 and the average weighting 0.2%.

Quarter-by-quarter ownership
Geneva Advisors, LLC ownership history of ARATANA THERAPEUTICS INC
ValueSharesWeighting
Q2 2017$579,000
+41.2%
80,118
+3.7%
0.01%
+42.9%
Q1 2017$410,000
-23.1%
77,288
+4.1%
0.01%
-30.0%
Q4 2016$533,000
-19.8%
74,244
+4.5%
0.01%
-16.7%
Q3 2016$665,000
+50.5%
71,038
+1.6%
0.01%
+33.3%
Q2 2016$442,000
+11.6%
69,908
-2.5%
0.01%
+12.5%
Q1 2016$396,000
+134.3%
71,687
+137.3%
0.01%
+166.7%
Q4 2015$169,000
-53.6%
30,207
-29.9%
0.00%
-57.1%
Q3 2015$364,000
-1.1%
43,074
+77.0%
0.01%0.0%
Q2 2015$368,000
+41.0%
24,329
+49.0%
0.01%
+40.0%
Q1 2015$261,000
+9.7%
16,328
+22.2%
0.01%
+25.0%
Q4 2014$238,00013,3580.00%
Other shareholders
ARATANA THERAPEUTICS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Engaged Capital LLC 3,487,149$21,376,0003.96%
Broadfin Capital, LLC 4,083,135$25,030,0003.29%
MPM ASSET MANAGEMENT LLC 250,000$1,533,0001.30%
GENERAL AMERICAN INVESTORS CO INC 1,599,365$9,804,0001.03%
Grandeur Peak Global Advisors, LLC 821,038$5,033,0000.65%
CADENCE CAPITAL MANAGEMENT LLC 307,294$1,884,0000.19%
Redmond Asset Management, LLC 60,176$369,0000.18%
Alambic Investment Management, L.P. 65,000$398,0000.17%
MENTA CAPITAL LLC 39,562$243,0000.09%
Campbell & CO Investment Adviser LLC 12,990$88,0000.09%
View complete list of ARATANA THERAPEUTICS INC shareholders